Source:http://linkedlifedata.com/resource/pubmed/id/16319541
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-12-1
|
pubmed:abstractText |
There is substantial evidence that treatment with lipid-lowering agents can decrease cardiovascular morbidity and total mortality in patients with elevated serum lipid values and/or prior ischaemic heart disease. However, only a minority of these high-risk patients are believed to receive treatment, and among those who do receive pharmaceutical treatment the majority do not reach the therapeutic goal. Our goal was to investigate if this translates to a higher risk of cardiovascular events in real clinical practice.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1741-8267
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
530-4
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:16319541-Cardiovascular Diseases,
pubmed-meshheading:16319541-Female,
pubmed-meshheading:16319541-Follow-Up Studies,
pubmed-meshheading:16319541-Humans,
pubmed-meshheading:16319541-Hyperlipidemias,
pubmed-meshheading:16319541-Hypolipidemic Agents,
pubmed-meshheading:16319541-Incidence,
pubmed-meshheading:16319541-Inpatients,
pubmed-meshheading:16319541-Lipids,
pubmed-meshheading:16319541-Male,
pubmed-meshheading:16319541-Middle Aged,
pubmed-meshheading:16319541-Retrospective Studies,
pubmed-meshheading:16319541-Survival Rate,
pubmed-meshheading:16319541-Sweden,
pubmed-meshheading:16319541-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
Association between achieving treatment goals for lipid-lowering and cardiovascular events in real clinical practice.
|
pubmed:affiliation |
Stockholm Health Economics, Stockholm, Sweden. peter.lindgren@healtheconomics.se
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|